Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021).
10.3760/cma.j.cn112138-20211109-00786
- VernacularTitle:原发性硬化性胆管炎诊断及治疗指南（2021）
- Collective Name:Chinese Society of Hepatology, Chinese Medical Association
- Publication Type:Practice Guideline
- Keywords:
Diagnosis;
IgG4-related sclerosing cholangitis;
Practice guideline;
Primary sclerosing cholangitis;
Therapeutics
- MeSH:
Autoimmune Diseases/diagnosis*;
Cholangitis, Sclerosing/therapy*;
Diagnosis, Differential;
Humans;
Immunoglobulin G
- From:
Chinese Journal of Hepatology
2022;30(2):169-189
- CountryChina
- Language:Chinese
-
Abstract:
In 2015, the first Chinese consensus on the diagnosis and management of primary sclerosing cholangitis was issued. In the past years, more data have emerged from the literature. Herein, the Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review the evidence and updated the recommendations to formulate the guidelines. There are 21 recommendations on PSC clinical practice. To facilitate the differentiation between PSC and IgG4-related sclerosing cholangitis, 10 recommendations on IgG4-SC are also attached. These guidelines aim to provide a working reference for the management of PSC and IgG4-SC.
